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Loss of retinal ganglion cells (RGCs) is a hallmark of many ophthalmic diseases including 
glaucoma, retinal ischemia due to central artery occlusion, anterior ischemic optic neuropathy and 
may be significant in optic neuritis, optic nerve trauma, and AIDS. Recent research indicates that 
neurotoxicity is caused by excessive stimulation of receptors for excitatory amino acids (EAAs). In 
particular, the amino acid glutamate has been shown to act as a neurotoxin which exerts its toxic 
effect on RGCs predominantly through the N-methyl-o-aspartate (NMDA) subtype of glutamate 
receptor. NMDA-receptor-mediated toxicity in RGCs is dependent on the influx of extracellular 
Ca z+. The increase in [Ca2+]i acts as a second messenger that sets in motion the cascade leading to 
eventual cell death. Glutamate stimulates its own release in a positive feedback loop by its 
interaction with the non-NMDA receptor subtypes. Ca2÷-induced Ca z- release and further inflax of 
Ca z+ through voltage-gated Ca 2+ ctmnnels after glutamate-induced depolarization contribute to 
glutamate toxicity. In vitro and in vivo studies suggest hat the use of selective NMDA receptor 
antagonists or Ca 2+ channel blocker's hould be useful in preventing or at least abating neuronal 
loss in the retina. Of particular importance for future clinical use of NMDA receptor antagonists in
the treatment of acute vascular insults is the finding that some drugs can prevent glutanaate- 
induced neurotoxicity, even when administered a few hours after the onset of retinal ischemia. 
© 1997 Published by Elsevier Science Ltd 
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INTRODUCTION 
Pathological activation of glutamate receptors i  thought 
to be a final common pathway leading to neuronal 
damage in the course of many neurological diseases uch 
as hypoxic-ischemic brain injury, epilepsy, Huntington's 
disease, Parkinson's disease, Alzheimer's disease, and 
HIV-associated ementia (for a review with original 
references, ee Lipton & Rosenberg, 1994). Diseases of 
the eye and retina that are likely to involw'~ glutamate 
receptor-mediated toxicity, at least to some degree, are 
glaucoma (including open angle glaucoma, chronic angle 
closure glaucoma and pseudo-exfoliative glaucoma), 
central and branch retinal arterial and retinal vein 
occlusions. Moreover, anterior ischemic optic neuropa- 
thy, optic neuritis (at least drug-induced) and optic nerve 
trauma possibly involve glutamate-related toxicity. 
Several of the above mentioned systemic diseases, such 
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as Alzheimer' s disease and the HIV-associated ementia, 
have been reported to affect he retinal ganglion cell layer 
(Hinton et al., 1986; Tenhula, Xu, Madigan, Heller, 
Freeman, & Sadun, 1992). 
Glutamate, or related excitatory amino ~Lcids (EAAs), 
are thought to mediate xcitatory synaptic transmission at
the photoreceptor/bipolar cell synapses and at the bipolar/ 
ganglion cell synapses, acting through activation of 
glutamate receptors. Glutamate is probably the excitatory 
transmitter used by retinal ganglion cells (RGCs). EAAs 
acting at specific membrane receptors also influence 
neuronal plasticity and survival, and EAA receptor 
activation plays an important role in the development 
of the visual system (Kleinschmidt, Bear, & Singer, 
1987; Lipton & Kater, 1989; Simon, Prusky, O'Leary, & 
Constantine-Paton, 1992; Komuro & Rakic, 1993). 
Glutamate receptors have been divided according to 
their primary signal transduction mechanism into iono- 
tropic and metabotropic receptor subtypes (Nakanishi, 
1992). The ionotropic glutamate receptors have been 
named according to their preferred agonists the N- 
methyl-D-aspartate (NMDA), ~-amino-3-hydroxyl-5- 
methyl-isoxazol-4-propionic acid (AMPA), and kainate 
subtypes. The latter two types are also refelTed to as non- 
NMDA receptors since the functional properties between 
the two groups are not totally distinct. 
This article will review experimental evidence from 
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our laboratories that glutamate itself can act as a major 
neurotoxin in the retina and that EAA-induced neuro- 
toxicity in RGCs is predominately mediated by NMDA 
receptors, at least under certain conditions. Potential 
mechanisms of toxicity at the molecular level down- 
stream of glutamate receptor activation are described. 
Finally, the significance of these findings for possible 
therapeutic strategies toprevent or abate loss of RGCs as 
a consequence of ophthalmic diseases are discussed. 
PHYSIOLOGY OF RGCS 
RGCs are the converging endpoint of retinal informa- 
tion processing (W~issle & Boycott, 1991). The result of 
retinal preprocessing of visual information is transmitted 
to subsequent areas in the brain in the form of trains of 
action potentials that travel along RGC axons. Mamma- 
lian RGCs receive excitatory and inhibitory input from 
bipolar, amacrine and other RGCs through chemical 
synapses. Accordingly, RGCs express a variety of 
neurotransmitter r ceptors and voltage-gated ion chan- 
nels. Of particular importance for both the physiological 
function of RGCs and pathophysiological hanges that 
can lead to cell death are those receptors and ion channels 
that influence the intracellular Ca 2+ concentration 
([Ca2+]i) of RGCs (Lipton & Kater, 1989). 
Ca 2+ ions serve as ubiquitous intracellular second 
messenger molecules. The [Ca2+]i determines the 
activity of many ion channels and enzymes either directly 
or indirectly through activation or inactivation of 
enzymes like phospholipases, phosphokinases and phos- 
phatases. Ca 2+ influx from the extracellular space and the 
Ca 2+ flux into and out of intracellular compartments are 
tightly regulated, and Ca 2+ itself can serve as both a 
positive and negative regulator of [Ca2+]i. For example, 
influx of Ca 2+ has been shown to stimulate further elease 
of Ca 2+ from intracellular stores. This effect of Ca 2+ has 
been termed CaZ+-induced Ca 2+ release and has been 
shown to be particularly important in RGCs Lei et al., 
1992; Leinders-Zufall, Rand, Waxman, & Kocsis, 1994). 
RGCs from rat have been studied in great detail using 
the patch-clamp technique (Lipton, Aizenman, & Loring, 
1987; Lipton & Tauck, 1987; Aizenman, Frosch, & 
Lipton, 1988; Aizenman, Lipton, & Loring, 1989; 
Karschin, Aizenman, & Lipton, 1988; Lipton, 1988; 
Tauck, Frosch, & Lipton, 1988; Karschin & Lipton, 
1989; Lipton, 1989; Sucher, Aizenman, & Lipton, 
1991a,b,c; Pan, B~hring, Grantyn, & Lipton, 1995). 
They possess receptors for excitatory transmitters such as 
acetylcholine (Lipton et al., 1987) and glutamate or 
related EAA (Aizenman et al., 1988; Zhang & Lipton, 
1992) and receptors for the inhibitory neurotransmitters 
GABA and glycine (Tauck et al., 1988; Lipton, 1989; Pan 
et al., 1995). It has been shown that virtually all rat 
neonatal RGCs possess EAA receptors of the non- 
NMDA and/or the NMDA type (Aizenman et al., 1988). 
Transcripts for many subunits of the glutamate receptor 
family have been found in rat RGCs by in situ 
hybridization (Hamassaki, Hermans, Heinemann, & 
Hughes, 1993; Brandstatter, Hartveit, Sassoe-Pognetto, 
& W~issle, 1994). Interestingly, individual RGCs appear 
to co-express transcripts for multiple subunits (Hamassa- 
ki et al., 1993). NMDA, certain non-NMDA receptors, 
and nicotinic acetylcholine r ceptors are d!irectly perme- 
able to Ca 2+. Moreover, it has been demonstrated that 
CaZ+-induced Ca 2+ release is responsible :for up to 50% 
of the increase in [Ca2+]i following NMDA receptor 
activation in RGCs (Lei et al., 1992a). 
Recent studies from several laboratories have demon- 
strated that RGCs possess CaZ+-permeable non-NMDA 
receptors (R6rig & Grantyn, 1993; Leinders-Zufall et al., 
1994; Zhang, Sucher, & Lipton, 1995). The kainate- 
evoked current is generally much larger than that evoked 
by NMDA in RGCs and it is non-desensitizing. The Ca 2t 
permeability coupled with the rate of desensitization f 
the non-NMDA receptors determine how much Ca 2+ 
enters the cell via these channels. A l~xge sustained 
response to glutamate and a higher permeability oCa 2+ 
will work synergistically to allow greater influx of Ca 2+ 
into RGCs. Therefore, the amount of Ca 2+ entering 
through AMPA/kainate receptor-operated channels in 
RGCs might be considerable, ven though the Pcd+/Pcs+ 
value for non-NMDA receptors has been found to be 
about 10-times lower than that for NMDA receptors in 
RGCs. In individual RGCs, the combination of multiple 
glutamate receptor subunits to form single channels, as 
well as the co-expression of the resulting multiple 
channel types determine the response to glutamate 
(Zhang et al., 1995). In addition, voltage-gated Ca 2+ 
channels allow further influx of Ca 2+ after glutamate- 
induced epolarization. 
The combined effect of NMDA/non-NMDA receptor- 
mediated excitatory and GABA/glycine receptor- 
mediated inhibitory inputs together with the activation 
state of voltage-gated ion channels determines the 
membrane potential of RGCs. Rat RGCs express a 
variety of voltage-gated ion channels (Lipton & Tauck, 
1987; Karschin & Lipton, 1989; Sucher & Lipton, 1992; 
Taschenberger & Grantyn, 1995). Of particular impor- 
tance for the biochemistry ofRGCs are voltage-gated ion 
channels that are permeable toCa 2+ ions. RGCs possess a
variety of voltage-gated Ca2+ channels including N-, T-, 
L- and possibly Q-type channels (Karschin & Lipton, 
1989; Rayudu, Chen,& Lipton, 1995; Taschenberger & 
Grantyn, 1995). Of particular importance for the discus- 
sion of the etiology of RGC neurotoxicity and possible 
therapeutic prevention of cell death are the L-type 
calcium channels because of their prolonged action and 
availability of inhibitory drugs (Karschin & Lipton, 
1989). 
GLUTAMATE AS A MAJOR RETINAL NEUROTOXIN 
IN  VIVO 
Lucas & Newhouse (1957) first reported the toxic 
effects of glutamate on the mammalian eye. Subcuta- 
neous injection of glutamate into young mice led to 
severe destruction of the inner retina]l ayers, most 
notably in the retinal ganglion cell layer. Using 
ultrastmctural techniques, Olney demonstrated similar 
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FIGURE 1. Toxicity of chronic administration f glutamate othe retinal ganglion cell layer. Adult rats were anesthetized, and one: eye of each rat 
injected under direct visualization every 5 days with 1 ml of a 5 mM solution of glutamate. The contralateral eye was used as a control, and was 
injected with 1 ml of vehicle on the same days. The glutamate-treated rat retina (right) shows a diminution of the cells in the retinal ganglion cell 
layer (GCL) when compared with the control eye (left). Accordingly, chronic glutamate administration is toxic to cells of the retinal ganglion 
layer. Note the diminution of the retinal ganglion cell layer, with sparing of the other layers of the retina. This finding is strikingly similar in 
appearance to human glaucomatous retina (not illustrated). INL, inner nuclear layer; ONL, outer nuclear layer. Scale bar: 15 pm. 
glutamate-induced retinal toxicity in neonatal mice, and 
coined the term "excitotoxicity" to describe these lesions 
(Olney, 1982). Sisk & Kuwabara (1985) injected 
glutamate intravitreally into adult albino rats and 
observed egeneration of the inner nuclear and ganglion 
cell layers. 
These classical studies demonstrated that acute admin- 
istration of intravitreal glutamate is severely toxic to the 
inner layers of the retina. However, the effect of a chronic 
elevation in vitreal glutamate on the retina had not been 
explored until recently (Samy, Lui, Kaiser, Lipton, & 
Dreyer, 1994; Vorwerk, Lipton, Zurakowski, Hyman, 
Sabel, & Dreyer, 1996). To do this, one eye of adult rats 
received an intravitreal injection of glutamate (1 ~tl of a 
5 mM solution) every 5 days for 3 months. This injection 
elevated vitreal glutamate to --~ 30/~M, compared to a 
baseline value of ,-~5 #M in the ~ontrol eye. The 
contralateral eye received an injection of control vehicle. 
Histologic sections were prepared from both glutamate 
treated and control eyes, and cells in the retinal ganglion 
cell layer were counted in a masked fashion. This 
treatment resulted in selective damage to the retinal 
ganglion cell layer (Fig. 1). The number of cells in the 
retinal ganglion cell layer in eyes treated with chronic 
glutamate was 56 000 + 9600 cells per retina (n = 8). The 
retinal ganglion cell layer in control eyes contained 
96 500-+-8500 cells per retina (n = 8). This difference 
was statistically significant (P < 0.001; non-parametric 
Wilcoxon rank sum test with Bonferroni procedure). No 
changes were seen in eyes treated with glutamate for less 
than 30 days, suggesting that chronic administration was 
necessary for the observed effect at these low concentra- 
tions of glutamate. These results indicate that chronic 
glutamate administration is deleterious to the retinal 
ganglion cell layer. Interestingly, chronic administration 
results in a histologic pattern similar to that ..~een with an 
acute bolus of intravitreal glutamate, and is remarkably 
similar to the histopathology seen in hum~n glaucoma 
(Schumer & Podos, 1994; Dreyer, Zurakowski, Schumer, 
Podos, & Lipton, 1995c). 
IN VITRO MODEL OF GLUTAMATE TOXICITY IN 
RGCS 
In order to investigate glutamate toxicity in RGCs 
under well controlled and defined conditiom~, short-term 
in vitro culture of freshly dissociated RGCs was 
developed (Leifer, Lipton, Barnstable, & Masland, 
1984; Hahn, Aizenman, & Lipton, 1988). In this model 
system, rat RGCs are labeled in situ by retrograde 
transport of a fluorescent dye. The dye is injected into the 
superior colliculus of 4-9-day-old animals under an- 
esthesia. The animals are sacrificed 2 days after injection, 
enucleated, and the retinas removed. Retinas are treated 
with papain and mechanically dissociated for plating by 
trituration. Living RGCs can be identified by the presence 
of granular blue and by the uptake and cleavage of 
fluorescein diacetate to fluorescein (Fig. 2). Toxicologi- 
cal studies or patch-clamp recordings can be performed 
4 48 hr after plating. RGCs comprise about 1% of the 
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FIGURE 2, Caption on facing page. 
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cells in these short-term cultures. Eighty five to ninety 
percent of the RGCs are commonly found in small 
clusters with other retinal cells while the remaining cells 
are solitary RGCs (Lipton, 1986). Thus, the biophysical 
and pharmacological characterization f ion channels can 
be carried out in the same culture system that is used for 
toxicity studies (Levy, Sucher, & Lipton, 1990, 1991; 
Sucher et al., 1991a,c). 
Using such RGC cultures, it has been demonstrated 
that glutamate, NMDA, kainate, endogenous glutamate 
or a glutamate-like toxin kills RGCs in a Ca2+-dependent 
manner (Hahn et al., 1988; Sucher et al., 1991a). The 
association between rises in [Ca2-]i and subsequent 
neuronal death was reinforced by the finding that 
activation of NMDA receptor-operated channels via a 
redox modulatory site increases both NMDA-induced 
neuronal injury and NMDA-receptor activated Ca 2+ flux 
(Levy et al., 1990; Sucher, Wong, & Lipton, 1990; Levy 
et al., 1991; Sucher & Lipton, 1991). 
Excitotoxicity in RGCs caused by either endogenous 
toxin(s) or exogenously added NMDA or glutamate could 
be blocked by NMDA receptor antagonists or L-type 
Ca 2+ channel blockers (Lipton, 1991, Lipton, Sucher, 
Kaiser, & Dreyer, 1991; Sucher et al., 1991c). HPLC 
analysis of the culture medium indicated that RGC 
cultures contained ,-~ 26 i tM glutamate, suggesting that 
this EAA itself may be the endogenous toxin (Lipton et 
al., 1991). In order to directly test this hypothesis, RGC 
cultures were incubated with the enzyme glutamate- 
pyruvate transaminase (GPT). This enzyme catalyzes the 
transamination f glutamate to 2-ketoglutarate while the 
required co-substrate pyruvate goes to alanine. GPT- 
treatment abrogated toxicity due to the endogenous toxin 
in the presence, but not absence, of pyruvate. HPLC 
analysis confirmed that addition of GPT and pyruvate 
reduced the glutamate concentration in the treated 
cultures to below 7/~M (Lipton et al., 1991). Thus, 
glutamate appeared to be required for the manifestation 
of excitotoxicity in RGC cultures. A simple explanation 
consistent with these data is that glutamate itself is an 
endogenous toxin causing RGC death by activating 
NMDA receptors. 
In order to assess more directly the possible role of 
non-NMDA receptors in glutamate-mediated oxicity, a 
separate set of experiments was performed (Sucher et al., 
1991a). Addition of kainate (125/tM) to neonatal RGC 
cultures increased the proportion of RGCs that die 
compared with sibling cultures not receiving kainate. 
The toxicity due to both kainate and/or the endogenous 
toxin was blocked by addition of the competitive NMDA 
receptor antagonist 2-amino-5-phosphonovalerate 
(APV). However, only a portion of kainate-induced 
toxicity was blocked by the non-NMDA receptor 
antagonist 6-cyano-7-nitroquinoxaline-2,3-dione 
(CNQX). These data indicate that either kainate might 
activate NMDA receptors or that kainate might activate 
AMPA/kainate receptors and stimulate the release of 
endogenous glutamate, which in turn would ldll RGCs by 
activating NMDA receptors. Patch-clamp recordings 
demonstrated that kainate-evoked currents were not 
affected by NMDA antagonists, thus arguing against 
he first possibility. Since GPT/pyruvate blocked the 
toxicity due to endogenous toxin, it is likely that 
stimulation of non-NMDA type glutamate receptors 
leads to an increase in the release of endogenous 
glutamate. It is not known, however, if toxic glutamate 
levels are reached by synaptic release of this amino acid 
alone and/or due to glutamate release from dying cells. 
The blockade of electrical activity by addition of the 
sodium channel blocker tetrodotoxin (TTX) to these 
cultures also promoted the death of clustered RGCs 
derived from postnatal days 2-10 animals (Lipton, 1986; 
Kaiser & Lipton, 1990). Thus, it has not been possible to 
evaluate the contribution of synaptic glutamate release to 
excitotoxicity. 
It has been shown that glaucoma p,referentially 
damages larger RGCs (Glovinsky, Quigley, & Dunkel- 
berger, 1991; Chaturvedi, Hedley-Whyte, & Dreyer, 
1993; Glovinsky, Quigley, & Pease, 1993), and this has 
also been suggested in Alzheimer's disease (Hinton et al., 
1986) and possibly in AIDS (Tenhula et al., 1992). 
Previous experiments uggested that, in vitro, larger 
RGCs show greater susceptibility to glutamate-induced 
cell stress, as evidenced by increased production of heat 
shock proteins. Recently, a study was undertaken to 
explore directly whether larger RGCs mi~ght be more 
sensitive to glutamate-mediated neuronal cell death in 
vitro and in vivo (Dreyer, Pan, Storm, & Lipton, 1994). 
When cultured RGCs were scored based on viability and 
size in the face of incubation with glutamate, it was found 
that the smaller RGCs were apparently not very sensitive 
to the addition of exogenous glutamate. Glutamate 
(100pM) had little effect on RGC viability for cells 
smaller than 7.7 ¢tm in diameter. Only larger RGCs were 
killed in this experimental paradigm (960 RGCs were 
scored by size in four experiments; ignificant by paired 
t-test, P < 0.001). Results similar to these in culture were 
also seen in the intact animal. Rodent eyes were injected 
with NMDA, and the animals sacrificed '7 days later. 
When viable cells were scored by size (n = 1200), the 
mean cell size in the control eyes was statistically larger 
than in eyes treated with an intravitreal injection of 
FIGURE 2. (opposite) Photomicrographs of RGCs in cell culture following a ~ 20 hr incubation with 1 mM glutamate (with permission from 
Hahn et al., 1988). Photographs were taken from the same field under standard UV and fluorescein filter sets. (A) RGCs are shown under a 
combination of phase contrast and UV epifluorescence. Two RGCs are identified by their blue fluorescence b cause of prior labeling and 
retrograde transport of the fluorescent dye granular blue. Other etinal cells are not labeled. Cellular debris can be seen in Lhe picture as a 
consequence of disintegrating cells due to glutamate-induced cytotoxicity. (B) Live RGCs can be distinguished from dead RGCs by the uptake 
and cleavage ofthe green fluorescent dye fluorescein diacetate (arrow). Dead RGCs are not fluorescent (arrow head). Other etinal cells visible in 
this field are alive by this criterion. 
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NMDA (n = 3; significant by paired t-test, P < 0.05). 
NMDA had little effect on RGCs smaller than 7.7 #m in 
diameter. RGCs larger than this diameter were sensitive 
to NMDA-induced eath. 
The ability of RGCs to survive an NMDA excitotoxic 
challenge in vitro was scored as a function of the 
presence of neurites, and the number of neurite branch 
points (Heng, Moscaritolo, & Dreyer, 1995). It has been 
found that RGCs with processes were far more sensitive 
to NMDA-mediated excitotoxicity than RGCs without 
such neurites. Susceptibility oNMDA toxicity increased 
with process length. For example, NMDA was toxic to 
29% of the RGCs with a total neurite length of between 
25 and 50 microns, but the same dose of NMDA killed 
58% of the cells with a process length between 101 and 
125 microns. NMDA toxicity was abrogated by the 
addition of 12/~M of the NMDA antagonist MK-801 
(dizocilpine). MK-801 had no effect on ganglion cell 
survival alone. Those cells with longer neurites were 
more likely to have an increased number of neurite 
branch points; consequently, cells with more branch 
points were also more susceptible to NMDA toxicity. 
However, this finding is dependent on the primary result, 
i.e., sensitivity to NMDA toxicity was increased in cells 
with longer neurites. 
"DOWNSTREAM" MECHANISMS OF GLUTAMATE 
TOXICITY 
NMDA-receptor mediated excitotoxicity in RGCs has 
been shown to be dependent on the influx of extracellular 
Ca 2+ (Hahn et al., 1988) and the block of L-type Ca 2+ 
channels by dihydropyridines has been found to attenuate 
toxicity in RGCs due to either the endogenous EAA- 
related neurotoxin(s) or exogenous glutamate and 
NMDA (Dreyer, Kaiser, Offermann, & Lipton, 1990; 
Lipton, 1991; Sucher et al., 1991c). It is thought that the 
increase in [Ca2+]i acts as a second messenger that leads 
to changes in the baseline activity of a number of 
enzymes and in turn sets in motion the cascade leading to 
eventual cell death (Fig. 3). Interestingly, however, 
elevation of [Ca2+]i due to depolarization of RGCs by 
high concentrations of extracellular K + appears to cause 
less neuronal damage than similar [Ca2+]i ncreases 
induced by glutamate (S. A. Lipton, unpublished 
observation). It has not been established yet if the 
location or mode of entry of Ca 2-- are critical or if 
activation of glutamate r ceptors leads to the generation 
of additional, as yet unidentified messengers that 
contribute to neurotoxicity. 
A possible contributor to the glutamate-activated 
cascade leading to cell death is neuronal nitric oxide 
synthase (nNOS). The critical role of nNOS in neuronal 
function has been demonstrated in a plethora of studies 
over the past half dozen years. Intense interest has 
focused on the role of nitric oxide in excitotoxicity since 
the publication of a report linking NMDA receptor- 
mediated neurotoxicity and nitric oxide production. In 
several subsequent s udies, however, apparently contra- 
dictory results were obtained when nitric oxide was found 
to be neurodestructive n some studies but neuroprotec- 
tive in others (Dawson, Dawson, London, Bredt, & 
Snyder, 1991; Lei et at., 1992; Moncada, Lekieffre, 
Arvin, & Meldrum, 1992; Dawson, Dawson, Bartley, 
Uhl, & Snyder, 1993; Lipton et at., 1993). These 
apparently contradictory findings could be explained, at 
least in part, by a redox-based mechani,;m taking into 
account hat nitric oxide proper is only one of three 
possible redox forms of nitrogen monoxide (NO) (Lipton 
et al., 1993). NO-related neurotoxicity is probably 
mediated by the generation of peroxynitrite (ONOO-) 
by the reaction of NO (true nitric oxide with an unpaired 
electron) with superoxide anion (02.-). The NO group in 
the NO + form (with one less electron than NO.) exerts its 
neuroprotective effects by down-regu]Iating NMDA 
receptor activity via reaction with a redox modulatory 
site consisting of critical cysteine sulflaydryl groups. 
Among the modulatory sites of the NMDA receptor, 
these so-called redox modulatory sites of the NMDA 
receptor are of particular interest since manipulation of
the redox state influences NMDA receptor-mediated 
neurotoxicity (Levy et al., 1990, 1991). 
The redox modulatory sites of the NMDA receptor are 
operationally defined by the effect of the reducing and 
oxidizing agents dithiothreitol (DTT) and 5,5'-dithio-bis- 
(2-nitrobenzoic acid) (DTNB) (Aizenman et al., 1989). 
Extracellular application of DTT increases ionic currents 
through the NMDA receptor-gated ion channel; DTNB 
decreases this current. Up-regulation of the NMDA 
receptor-gated ion channel current by DTT is reversed by 
application of DTNB, and downregulation following 
DTNB application is reversed by subsequent exposure to 
DTT. The sulfhydryl group alkylating agent N-ethylma- 
leimide (NEM) irreversibly blocks the effect of both 
drugs (Lei et al., 1992). Thus, sulfhydryl groups are 
likely to be important for the formation of the redox 
modulatory site. This modulatory site acts like a gain 
switch controlling channel activity. Neither the channel 
pore itself nor the receptor binding sites for glutamate or 
glycine appear to be affected by redox modulation 
(Sucher et al., 1990). Recent experiments with mutant 
subunits in which cysteines were changed by site- 
directed mutagenesis identified at least two cysteines in 
the NMDAR1 subunit that appear to be required for 
redox modulation (Sullivan, Traynelis, Chen, Escobar. 
Heinemann, & Lipton, 1994). 
NMDA receptor-mediated neurotoxicity in RGCs 
increased with DTT treatment, and 1:his effect was 
blocked by DTNB (Levy et al., 1990). These findings 
suggest hat the redox state of the NMDA receptor is 
crucial for the survival of neurons facing glutamate- 
related injury. Endogenous redox agents, such as free 
radicals, glutathione, ascorbate and others, have been 
shown to directly or indirectly influence this redox site(s). 
Both oxidized and reduced glutathione have been found 
to be protective and to attenuate RGC damage mediated 
by NMDA receptor activation (Levy et al., 1991; Sucher 
& Lipton, 1991). Consistent with these findings, oxidized 
glutathione was effective as a down~:egulator at the 
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FIGURE 3. Diagram of the pathophysiology of glutamate-induced toxicity in RGCs. *Mild insults (low-dose glutamate or
NMDA) lead to RGC death through apoptosis while intense insults (high-dose glutamate orNMDA) are more likely to produce 
RGC necrosis. 
NMDA receptor redox sites. Interestingly, reduced 
glutathione was ineffective as a redox modulator of 
NMDA receptors but instead enhanced inhibitory GABA 
currents in RGCs (Pan et al., 1995). 
The role of NOS in the eye, and in particular the retina 
has been investigated recently by using mice deficient in 
neuronal and endothelial NOS. (Dreyer et al., 1995a). 
The nNOS and eNOS deficient mouse (Huang, Dawson, 
Bredt, Snyder, & Fishman, 1993) and a control cohort 
were subjected to (a) intravitreal injections of NMDA; or 
(b) multiple retinal arterial occlusions induced either by 
thermal photocoagulation or photo-thrombosis. RGC 
survival was evaluated by retrograde transport of horse- 
radish peroxidase (HRP) and stereological analysis of 
retinal whole mounts. In the wild type mouse, 63% of the 
RGCs were killed by a single injection of 10 nmol of 
NMDA. In comparison, only 35% of the NOS-knockout 
RGCs were lost at this dose. Furthermore, with either 
retinal arterial occlusion model, the NOS-knockout 
mouse lost only half as many RGCs as the wild type 
mouse. Pre-injection with 100 #M of the NOS inhibitor, 
L-nitro-arginine also protected RGCs from both NMDA 
and arterial-occlusions. 
These data indicate that neuronal nitric oxide synthase 
appears to be critically involved in the full expression of 
retinal ganglion cell excitotoxicity mediated through 
NMDA receptors. These findings parallel the previously 
demonstrated relative resistance of the nNOS-mouse to 
cerebral ischemia. However, some residual NMDA 
toxicity can be seen in the nNOS-mouse, indicating that 
some RGCs are lost to an excitotoxic insult by a different 
pathway. One possibility is that other isoenzymes 
substitute for neuronal nitric oxide synthase (perhaps 
endothelial or inducible NOS) in the nNOS-mouse 
(Huang et al., 1993). However, there was no detectable 
difference between the response of the endothelial NOS 
deficeint mouse and control animals. Consequently, at 
least in this experimental paradigm, endothelial NOS is 
not critical for the expression of excitotoxicity. Alter- 
natively, as has been previously suggested (Dreyer, 
Zhang, & Lipton, 1995b), NMDA excitotoxicity in RGCs 
may develop through more than a single pathway, and 
only one of these potential pathways may require nNOS 
for full expression. Another potential factor for the lack 
of complete protection in the nNOS-deficiem ice is that 
NO'- equivalent as well as NO- should be decreased. 
Hence, in the nNOS knockout mice the beneficial effect 
of NO + in down-regulating NMDA receptor overactivity 
would be lost, leading to enhanced NMDA receptor- 
mediated neurotoxicity via pathways not involving NO-. 
Cell death has been classified as either necrotic or 
apoptotic. Necrosis and apoptosis are morphologically 
distinct mechanisms of cell death with w~ry different 
features (Ankarcrona et al., 1995; Bonfoco, Krainc, 
Ankarcrona, Nicotera, & Lipton, 1995). Necrosis has 
been associated with passive cell swelling, injury to 
cytoplasmic organelles including mitochondria, nd the 
rapid collapse of cellular homeostasis. Necrosis leads to 
membrane lysis, release of cellular contents, and 
resulting inflammation and consequent damage to 
neighboring cells. On the other hand, apoptosis has been 
regarded as an "active" process of neuronal cell 
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destruction with unique morphologic and molecular 
features. Apoptosis seen in both physiologic and 
pathologic onditions is characterized by cell shrinkage 
(often resulting in characteristic "apoptotic" bodies), 
membrane blebbing, chromatin condensation, and, if a 
nucleus is present, nuclear pyknosis and extensive 
genomic fragmentation. To prevent leakage of proteoly- 
tic enzymes, DNA, and oxidized lipids with a potential 
inflammatory response, apoptotic ells in some cases 
shield their intracellular milieu by cross-linking mem- 
brane proteins (Bonfoco et al., 1995). Interestingly, 
during normal development of the visual system, 
approximately one-third of immature retinal ganglion 
cells die by apoptosis (Young, 1984; Penfold & Provis, 
1986; Ilschner & Waring, 1992). It is conceivable that 
apoptosis may play a role not only during development, 
but may underlie the cell loss in a broad spectrum of 
disease states. It has also been reported that optic nerve 
transection causes retinal ganglion cell apoptosis in both 
adult and neonatal rats (Garcia-Valenzuela, Gorczyca, 
Darzynkiewicz, & Sherma, 1994; Rabacchi, Bonfanti, 
Liu, & Maffei, 1994). However, the exact mechanism 
underlying cell death after axotomy is not clear. Quigley 
and coworkers have recently demonstrated a role for 
apoptosis both in experimental primate glaucoma nd 
axotomy (Quigley, Nickells, Pease, Kerrigan, Thibault, 
& Zack, 1995). 
Recent experiments suggest that the addition of low 
doses of NMDA to RGCs initiates a cascade of cellular 
events including both translational nd transcriptional 
events leading to cell death (Dreyer et al., 1995b). 
Blockade of either translation with cycloheximide or 
transcription with actinomycin D effectively prevented 
retinal ganglion cell death resulting from exposure to low 
concentrations of NMDA, consistent with the prevention 
of apoptosis. These agents could be added 2 hr after the 
initial NMDA insult and could still protect against 
excitotoxicity. However, these agents were not protective 
at high doses of NMDA. The presence of actinomycin D 
or cycloheximide had no effect on NMDA-induced rises 
in intracellular calcium as monitored by fura-2 calcium 
imaging. 
A similar distinction between the effect of low and 
high doses of NMDA was recently described in cultures 
of cortical neurons (Bonfoco et al., 1995). It was found 
that low doses of NMDA or free radicals (including nitric 
oxide, superoxide anion and peroxynitrite) induced 
delayed death of neurons with the typical features of 
apoptosis, while high doses of NMDA led to immediate 
cell swelling and lysis with the features commonly found 
in necrosis. It is thus conceivable that actinomycin D and 
cycloheximide block the expression of genes that are part 
of the pathway(s) leading to apoptosis in RGCs. 
THERAPEUTIC IMPLICATIONS 
Using rat RGCs in our in vitro culture system, the 
uncompetitive NMDA receptor antagonist MK-801 
protected these neurons from NMDA receptor-mediated 
excitotoxicity even when administered 1-4 hr after the 
initial insult (Levy & Lipton, 1990). Importantly, the 
drug memantine has also been shown to be effective in 
preventing the NMDA receptor-mediated neurotoxicity 
when administered up to 4 hours after the insult 
(Pellegrini & Lipton, 1993). This drug has been used 
clinically in the treatment ofParkinson' s disease for more 
than a decade and its mild side-effect profile is well 
known. Memantine has been shown to be an open- 
channel blocker of the NMDA receptor. Its action is, 
therefore, similar to that of MK-801 and Mg 2+. The 
kinetics of the NMDA receptor charmel block by 
memantine are, however, significantly different from 
both of MK-801 and Mg 2+ with blocking and unblocking 
rates that are intermediate b tween the two (Chen et al., 
1992). In fact, the more rapid kinetics of channel 
blocking and un-blocking by memantine compared with 
MK-801 may be responsible for its lack of serious 
neurological side-effects (Lipton, 1993). 
The finding that actinomycin D and cycloheximide 
could be added 2hr after an initial mild NMDA insult and 
still protected against RGC excitotoxicity, points the way 
to the development of therapeutic strategies aimed at 
gene transcription orprotein translation. 
Ca 2+ channel antagonists ofthe dihydropyridine group 
have been shown to attenuate NMDA-receptor mediated 
neurotoxicity in RGCs both in vitro and in vivo. The 
dihydropyridines nimodipine and nifedipine were tested 
in the in vitro RGC culture system. The 'two drugs were 
found to attenuate the early rise in [Ca2+]i and the 
subsequent toxic effects of endogenous glutamate-related 
toxin or exogenous glutamate (Dreyer et al., 1990; 
Lipton, 1991; Sucher et al., 199lc). 
The effectiveness of the Ca 2+ channel blocker 
flunarizine was tested in vitro (Lipton, 1 c~91) and in vivo 
following optic nerve axotomy (Eschweiler & Bahr, 
1993). In this model, axotomy of the optic nerve leads to 
the death of RGCs within a few weeks, although their 
somata are not injured directly (Villegas, Vidal, Ras- 
minsky, Bray, & Aguayo, 1993). Flunarizine was given 
daily to rats (5 mg/kg body weight) after unilateral 
axotomy of the optic nerve. The density of retrogradely 
labeled RGCs was determined 14 days after axotomy. It
was found that flunarizine significantly enhanced RGC 
survival after axotomy in adult rats (P < 0.001; 
1065 ± 142 vs 922 4- 237 RGCs mm2). It remains to be 
established if flunarizine blocks the increase in [Ca]i that 
is induced by the axotomy per  se and/or if flunarizine 
prevents econdary excitotoxic RGC death (induced by 
glutamate that is released from damaged or dying cells). 
These findings should be of particular elevance for 
therapeutic strategies aimed at combating anglion cell 
loss in ophthalmic and neurologic diseases. RGCs are 
relatively resistant to calcium-dependent toxicity com- 
pared with many other types of central neurons. This 
results in a therapeutic advantage in that it takes man 3, 
hours for the RGCs to die. There may, therefore, be more 
time to intervene to save RGCs from the consequences of 
ischemic or hypoxic insults. Ca 2+ channel antagonists are 
widely used in clinical practice for the treatment of 
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hypertension and their clinical safety and side-effect 
profiles are well established. The NMDA receptor 
antagonist memantine is another drug that has been used 
extensively in clinical practice in Europe. It should 
therefore be relatively easy to plan and execute controlled 
studies as to the therapeutic efficacy of these drugs in 
diseases affecting RGCs. 
CONCLUSIONS 
RGCs co-express multiple NMDA and non-NMDA 
receptors with distinct functional properties. The func- 
tional diversity of these receptors plays an important role 
in controll ing Ca 2+-entry into RGCs. Glutamate has been 
shown to act as a endogenous neurotoxin which exerts its 
toxic effect on RGCs directly through the NMDA 
subtype of glutamate receptor. NMDA receptor-mediated 
toxicity in RGCs is dependent on the influx of 
extracellular Ca 2+. The increase in [Ca2+]i acts as a 
second messenger that sets in motion the cascade leading 
to eventual cell death. Glutamate stimulates its own 
release in a positive feedback loop by its interaction with 
the non-NMDA receptor subtypes. Ca2+-induced Ca 2+ 
release and further influx of Ca 2+ through voltage-gated 
Ca 2+ channels after glutamate-induced depolarization 
contribute to glutamate toxicity. Larger RGCs ( 10/am) 
appear to be more sensitive to NMDA receptor-mediated 
neurotoxicity both in vivo and in vitro. NMDA receptor 
antagonists or Ca 2+ channel blockers should be useful in 
preventing or at least abating neuronal loss in the retina. 
Some drugs can prevent glutamate-induced neurotoxicity 
even when administered a few hours after the onset of the 
insult. Further experiments may help to identify other 
aspects of the cellular pathways stimulated by toxic 
levels of excitatory amino acids 
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